Article citationsMore>>
Davies, S.M., Ramsay, N.K., Klein, J.P., Weisdorf, D.J., Bolwell, B., Cahn, J.Y., Camitta, B.M., Gale, R.P., Giralt, S., Heilmann, C., Henslee-Downey, P.J., Herzig, R.H., Hutchinson, R., Keating, A., Lazarus, H.M., Milone, G.A., Neudorf, S., Perez, W.S., Powles, R.L., Prentice, H.G., Schiller, G., Socié, G., Vowels, M., Wiley, J., Yeager, A. and Horowitz, M.M. (2000) Comparison of Preparative Regimens in Transplants for Children with Acute Lymphoblastic Leukemia. Journal of Clinical Oncology, 18, 340-347.
has been cited by the following article:
-
TITLE:
Low Dose Total Body Irradiation (600 cGy) as a Conditioning Regimen in Allogenic Hematopoietic Stem Cell Transplant in Children with Acute Lymphoblastic Leukemia
AUTHORS:
Alberto Olaya-Vargas, Martín Pérez-García, Nideshda Ramírez-Uribe, M. Angeles Del Campo-Martinez, Gerardo Lopez-Hernández, Montserrat Hernández-García, Jorge Amador-Zarco, Guadalupe Garcia-Vega, Yadira Melchor-Vidal, Marta Zapata-Tarres, Rocío Cárdenas-Cardos, Roberto Rivera-Luna
KEYWORDS:
Total Body Irradiation, Stem Cell Transplantation
JOURNAL NAME:
Journal of Cancer Therapy,
Vol.7 No.8,
August
10,
2016
ABSTRACT: Total body
irradiation (TBI) is conditioning regimen in children with acute lymphoblastic
leukemia (ALL) with a very high risk of relapse or in those who have not
achieved remission and have relapsed and subsequently received allogenic
hematopoietic stem cell transplantation (HSCT). A retrospective evaluation of
33 ALL patients in full remission with an indication of HSCT was performed to
evaluate overall survival (OS) and event-free survival (EFS). The inclusion
criteria included a myeloablative conditioning regimen of TBI at a dose of 600
cGy. The observed OS at 5 years was 50%, and the EFS of 32% we observed
difference in the EFS stem cell origin; the peripheral blood (PB) 60%, and the
umbilical cord blood (UC) accounted for 40%. Overall, 45% had a documented
chimerism. The OS at 5 years from patients with chimeras was 75%, while those
without chimeras had an OS at 5 years of 25%. The mortality in the first 100
days was 24%. A total of 24.2% of children presented with acute graft versus-host
disease (GVHD), while 33% had chronic GVHD. Currently, there is no general
agreement among all international centers regarding the optimum TBI dose. Our
study reports an acceptable range of adverse events with a relatively low dose
of 600 cGy.
Related Articles:
-
Chanda D. Gokhale, Shobha A. Udipi, Ramakrishna Y. Ambaye, Suresh K. Pai, Suresh H. Advani
-
Fatih M. Uckun, Sanjive Qazi
-
Rania A. Ghonaim, Tarek A. Elgohary
-
Sarah Tasneem, Lester Lipsky, Reda Ammar, Howard Sholl
-
Karolj Skala, Davor Davidović, Tomislav Lipić, Ivan Sović